Sequential Combination Therapy in Bladder Cancer

NCT03790384 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Mitomycin

Sponsor

Azienda Ospedaliera "Sant'Andrea"